Cargando…
Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway
BACKGROUND: Trans-cinnamaldehyde (TCA) is one of the main pharmaceutical ingredients of Cinnamomum cassia Presl, which has been shown to have therapeutic effects on a variety of cardiovascular diseases. This study was carried out to characterize and reveal the underlying mechanisms of the protective...
Autores principales: | Qian, Dongdong, Tian, Jing, Wang, Sining, Shan, Xiaoli, Zhao, Pei, Chen, Huihua, Xu, Ming, Guo, Wei, Zhang, Chen, Lu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040265/ https://www.ncbi.nlm.nih.gov/pubmed/35468773 http://dx.doi.org/10.1186/s12906-022-03594-1 |
Ejemplares similares
-
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy
por: Cipolletta, Ersilia, et al.
Publicado: (2015) -
The Role of CaMKII and ERK Signaling in Addiction
por: Jia, Wenbin, et al.
Publicado: (2021) -
LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII
por: Shao, Mingjing, et al.
Publicado: (2017) -
CaMKII points the way
por: Leslie, Mitch
Publicado: (2012) -
CaMKII in Cardiometabolic Disease
por: Ozcan, Lale, et al.
Publicado: (2014)